2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High prevalence of sexually transmitted infections and risk factors among HIV-positive individuals in Yunnan, China

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Yunnan has the highest rates of HIV in China. Other treatable sexually transmitted infections (STIs) are associated with accelerated HIV transmission and poor ART outcomes, but are only diagnosed by syndromic algorithms.

          Methods

          We recruited 406 HIV-positive participants for a cross-sectional study (204 ART-naive and 202 receiving ART). Blood samples and first-voided urine samples were collected. Real-time polymerase chain reaction methods were used for diagnosing Chlamydia trachomatis (CT), Neisseria gonorrhea (NG) and Mycoplasma genitalium (MG) . Syphilis and herpes simplex virus type 2 (HSV-2) tests were also performed.

          Results

          Among the 406 participants, the overall prevalence of STIs was 47.0% and 45.1% in ART-naive individuals and 49.0% in individuals receiving ART, respectively. The testing frequencies were 11.6% (11.8% vs. 11.4%), 33.2% (29.4% vs. 37.1%), 3.2% (3.4% vs. 3.0%), 2.0% (3.4% vs. 0.5%) and 4.7% (6.4% vs. 3.0%) for active syphilis, HSV-2, CT, NG and MG, respectively. The percentage of multiple infections in both groups was 10.8% (22/204) in ART-naive participants and 9.9% (20/202) in participants receiving ART. Female sex, an age between 18 and 35 years, ever injecting drugs, homosexual or bisexual status, HIV/HBV coinfection, and not receiving ART were identified as risk factors. Self-reported asymptomatic patients were not eliminated from having a laboratory-diagnosed STI.

          Conclusions

          The STI prevalence was 47.0% (45.1% vs. 49.0%), and HSV-2, syphilis and MG were the most common STIs in HIV-infected individuals. We found a high prevalence (6.4%) of MG in ART-naive individuals. HIV-positive individuals tend to neglect or hide their genital tract discomfort; thus, we suggest strengthening STI joint screening and treatment services among HIV-infected individuals regardless of whether they describe genital tract discomfort.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Contribution of sexually transmitted infections to the sexual transmission of HIV.

          We review recent evidence about the link between sexually transmitted infections (STI) and HIV transmission and consider implications for control programmes. New studies and meta-analyses confirm the association of HIV acquisition and transmission with recent STIs, although there is considerable heterogeneity between organisms and populations. Much of the recent evidence relates to herpes simplex virus type 2 (HSV-2), for which the population-attributable risk percentage (PAR%) for HSV-2 is between 25 and 35 in Africa. Mathematical models show how transmission attributable to STI varies with HIV epidemic phase, and HSV-2 becomes increasingly important as the epidemic matures. HSV-2 suppressive therapy reduces HIV concentrations in plasma and the genital tract in people coinfected with HSV-2, in part due to direct inhibition of HIV reverse transcriptase. Recent trials of HSV-2 suppressive therapy have not shown an impact on the risk of HIV acquisition, nor in controlling transmission from dually infected people to their serodiscordant heterosexual partners. Although there is a plausible link between STI and HIV risk, intervention studies continue to be disappointing. This fact does not disprove a causal link, but mechanisms of action and the design and implementation of interventions need to be better understood.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention.

            Sexually transmitted co-infections increase HIV infectiousness through local inflammatory processes. The prevalence of STI among people living with HIV/AIDS has implications for containing the spread of HIV in general and the effectiveness of HIV treatments for prevention in particular. Here we report a systematic review of STI co-infections in people living with HIV/AIDS. We focus on STI contracted after becoming HIV infected. Electronic database and manual searches located 37 clinical and epidemiological studies of STI that increase HIV infectiousness. Studies of adults living with HIV/AIDS from developed and developing countries reported STI rates for 46 different samples (33 samples had clinical/laboratory confirmed STI). The overall mean point-prevalence for confirmed STI was 16.3% (SD=16.4), and median 12.4% STI prevalence in people living with HIV/AIDS. The most common STI studied were Syphilis with median 9.5% prevalence, Gonorrhea 9.5%, Chlamydia 5%, and Trichamoniasis 18.8% prevalence. STI prevalence was greatest at the time of HIV diagnosis, reflecting the role of STI in HIV transmission. Prevalence of STI among individuals receiving HIV treatment was not appreciably different from untreated persons. The prevalence of STI in people infected with HIV suggests that STI co-infections could undermine efforts to use HIV treatments for prevention by increasing genital secretion infectiousness.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The changing face of HIV in China.

              HIV has advanced from high-risk groups such as intravenous drug users to some in the general population, according to comprehensive new data from the south of China. What needs to be done to halt its spread?
                Bookmark

                Author and article information

                Contributors
                yyeli2000@126.com
                yq610433@hotmail.com
                lulin@yncdc.cn
                Journal
                Eur J Med Res
                Eur J Med Res
                European Journal of Medical Research
                BioMed Central (London )
                0949-2321
                2047-783X
                13 January 2022
                13 January 2022
                2022
                : 27
                : 9
                Affiliations
                [1 ]GRID grid.285847.4, ISNI 0000 0000 9588 0960, Department of Public Health, , Kunming Medical University, ; Kunming, 650500 China
                [2 ]GRID grid.414902.a, ISNI 0000 0004 1771 3912, Department of Dermatology and Venereology, , First Affiliated Hospital of Kunming Medical University, ; Kunming, 650032 China
                [3 ]GRID grid.285847.4, ISNI 0000 0000 9588 0960, NHC Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, , Kunming Medical University, ; Kunming, 650032 China
                [4 ]GRID grid.508267.e, Yunnan Provincial Hospital of Infectious Diseases/Yunnan AIDS Care Center (YNACC), ; Anning, 650300 China
                [5 ]GRID grid.508395.2, ISNI 0000 0004 9404 8936, Yunnan Centers for Disease Control and Prevention, ; Kunming, 650022 China
                Author information
                http://orcid.org/0000-0003-0676-985X
                Article
                635
                10.1186/s40001-022-00635-w
                8756631
                35027093
                4408167a-3cc0-40d5-935b-41ba365c5bd3
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 27 September 2021
                : 4 January 2022
                Funding
                Funded by: Project of AIDS Bureau of Yunnan Province
                Award ID: 32060177
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81860553
                Award Recipient :
                Funded by: Ten-thousand Talents Program
                Award ID: YNWR-MY-2018-039
                Award Recipient :
                Funded by: the Medical Leadership Foundation of Health and Family Planning Commission of Yunnan Province
                Award ID: L-201613
                Award Recipient :
                Funded by: Yunnan Province Clinical Research Center for Skin Immune Diseases
                Award ID: 2019ZF012
                Award Recipient :
                Funded by: Yunnan Province Clinical Center for Skin Immune Diseases
                Award ID: ZX2019-03-02
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Medicine
                hiv,syphilis,ct,ng,mg,hsv-2,risk factor
                Medicine
                hiv, syphilis, ct, ng, mg, hsv-2, risk factor

                Comments

                Comment on this article